SKYE logo

Skye Bioscience (SKYE) Shareholders Equity

SKYE Annual Shareholders Equity

-$2.13 M
+$876.30 K+29.13%

01 December 2023

SKYE Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SKYE Quarterly Shareholders Equity

$75.80 M
+$2.99 M+4.11%

01 September 2024

SKYE Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SKYE Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+29.1%-3.9%
3 y3 years-572.9%+2407.6%
5 y5 years+86.3%+2407.6%

SKYE Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-136.3%+29.1%-3.9%+1073.2%
5 y5-year-136.3%+29.1%-3.9%+1073.2%
alltimeall time-136.3%+86.3%-3.9%+372.1%

Skye Bioscience Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$75.80 M(+4.1%)
June 2024
-
$72.81 M(-7.7%)
Mar 2024
-
$78.88 M(-3800.3%)
Dec 2023
-$2.13 M(-29.1%)
-$2.13 M(-225.7%)
Sept 2023
-
$1.70 M(-121.8%)
June 2023
-
-$7.79 M(+62.9%)
Mar 2023
-
-$4.78 M(+58.9%)
Dec 2022
-$3.01 M(-151.3%)
-$3.01 M(-8.4%)
Sept 2022
-
-$3.29 M(+988.5%)
June 2022
-
-$301.80 K(-110.2%)
Mar 2022
-
$2.97 M(-49.3%)
Dec 2021
$5.86 M(+1200.8%)
$5.86 M(-29.0%)
Sept 2021
-
$8.26 M(+263.9%)
June 2021
-
$2.27 M(-8.4%)
Mar 2021
-
$2.48 M(+449.8%)
Dec 2020
$450.80 K(-17.8%)
$450.80 K(-75.7%)
Sept 2020
-
$1.85 M(-159.9%)
June 2020
-
-$3.09 M(+81.7%)
Mar 2020
-
-$1.70 M(-410.7%)
Dec 2019
$548.10 K(-103.5%)
$548.10 K(-103.3%)
Sept 2019
-
-$16.40 M(+40.9%)
June 2019
-
-$11.64 M(-58.2%)
Mar 2019
-
-$27.86 M(+79.0%)
Dec 2018
-$15.56 M
-$15.56 M(+53.2%)
DateAnnualQuarterly
Sept 2018
-
-$10.16 M(+23.2%)
June 2018
-
-$8.25 M(+43.3%)
Mar 2018
-
-$5.75 M(+619.2%)
Dec 2017
-$800.10 K(-44.9%)
-$800.10 K(-62.0%)
Sept 2017
-
-$2.11 M(+18.4%)
June 2017
-
-$1.78 M(+44.6%)
Mar 2017
-
-$1.23 M(-15.3%)
Dec 2016
-$1.45 M(-408.0%)
-$1.45 M(+42.4%)
Sept 2016
-
-$1.02 M(+298.9%)
June 2016
-
-$255.50 K(-74.7%)
Mar 2016
-
-$1.01 M(-314.5%)
Dec 2015
$471.00 K(-203.9%)
$471.00 K(-54.1%)
Sept 2015
-
$1.03 M(-219.2%)
June 2015
-
-$861.00 K(+154.4%)
Mar 2015
-
-$338.40 K(-25.4%)
Dec 2014
-$453.50 K(-643.8%)
-$453.50 K(-158.4%)
Sept 2014
-
$776.30 K(+857.2%)
July 2014
-
$81.10 K(+10.5%)
Apr 2014
-
$73.40 K(-15.6%)
Jan 2014
-
$87.00 K(+4.3%)
Oct 2013
$83.40 K(+116.1%)
$83.40 K(+28.9%)
July 2013
-
$64.70 K(-1.4%)
Apr 2013
-
$65.60 K(+69.9%)
Oct 2012
$38.60 K
$38.60 K

FAQ

  • What is Skye Bioscience annual stockholders equity?
  • What is the all time high annual shareholders equity for Skye Bioscience?
  • What is Skye Bioscience annual shareholders equity year-on-year change?
  • What is Skye Bioscience quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Skye Bioscience?
  • What is Skye Bioscience quarterly shareholders equity year-on-year change?

What is Skye Bioscience annual stockholders equity?

The current annual shareholders equity of SKYE is -$2.13 M

What is the all time high annual shareholders equity for Skye Bioscience?

Skye Bioscience all-time high annual stockholders equity is $5.86 M

What is Skye Bioscience annual shareholders equity year-on-year change?

Over the past year, SKYE annual stockholders equity has changed by +$876.30 K (+29.13%)

What is Skye Bioscience quarterly stockholders equity?

The current quarterly shareholders equity of SKYE is $75.80 M

What is the all time high quarterly shareholders equity for Skye Bioscience?

Skye Bioscience all-time high quarterly stockholders equity is $78.88 M

What is Skye Bioscience quarterly shareholders equity year-on-year change?

Over the past year, SKYE quarterly stockholders equity has changed by -$3.08 M (-3.90%)